Evidence map›Paper›PMID 29988000›Full record

ArticleThe American journal of tropical medicine and hygiene2018

Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo.

Alexandra C Willcox, Matthew H Collins, Ramesh Jadi, Corinna Keeler, Jonathan B Parr, Dieudonné Mumba, Melchior Kashamuka, Antoinette Tshefu, Aravinda M de Silva, Steven R Meshnick

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06981442 (Implementation and Evaluation of Vector Control Methods in Kinshasa), which is not on this map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06981442 narecruitingnot on this mapstarted 2025, after this paper: background citation

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes, Vectors of Arboviruses.

TypeinterventionalSponsorInstitute of Tropical Medicine, BelgiumRan2025 to 2026Enrolled2,050ConditionsAedes-borne DiseasesArmsCommunity-based environmental management, Vector control against immature stages of Aedes, Vector control against the mature stages of Aedes
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Evidence of dengue virus transmission and a diversebioRxiv : the preprint server for biology · 2025
    Article
  11. Identification of AMOTL2 as an antiviral factor that enhances the human type I interferon response against Zika virus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Behavior of AdultTropical medicine and infectious disease · 2023
    Article
  18. Article
  19. Pattern ofTropical medicine and infectious disease · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Alexandra C WillcoxDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
Matthew H CollinsDepartment of Medicine, Division of Infectious Diseases, Hope Clinic of the Emory Vaccine Center, Emory School of Medicine, Decatur, Georgia.
Ramesh JadiDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Corinna KeelerDepartment of Geography, University of North Carolina, Chapel Hill, North Carolina.
Jonathan B ParrDepartment of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Dieudonné MumbaInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Melchior KashamukaEcole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Antoinette TshefuEcole de Santé Publique, Faculté de Médecine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Aravinda M de SilvaDepartment of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Steven R MeshnickDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
University of North Carolina at Chapel Hill · USUniversity of Kinshasa · CDEmory and Henry College · USNational Institute of Biomedical Research · CD

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Epidemiological and Spatial Models of Malaria TransmissionR01AI107949 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MESHNICK, STEVEN RICHARD · 2014 to 2018
$2.5M
NIAID NIH HHS R01 AI107949NICHD NIH HHS P2C HD050924
6 · The paper itself

Abstract

Flaviviruses such as Zika, dengue, and yellow fever cause epidemics throughout the tropics and account for substantial global morbidity and mortality. Although malaria and other vector-borne diseases have long been appreciated in Africa, flavivirus epidemiology is incompletely understood. Despite the existence of an effective vaccine, yellow fever continues to cause outbreaks and deaths, including at least 42 fatalities in the Democratic Republic of the Congo (DRC) in 2016. Here, we leveraged biospecimens collected as part of the nationally representative 2013-2014 Demographic and Health Survey in the DRC to examine serological evidence of flavivirus infection or vaccination in children aged 6 months to 5 years. Even in this young stratum of the Congolese population, we find evidence of infection by dengue and Zika viruses based on results from enzyme-linked immunosorbent assay and neutralization assay. Surprisingly, there was remarkable discordance between reported yellow fever vaccination status and results of serological assays. The estimated seroprevalences of neutralizing antibodies against each virus are yellow fever, 6.0% (95% confidence interval [CI] = 4.6-7.5%); dengue, 0.4% (0.1-0.9%); and Zika, 0.1% (0.0-0.5%). These results merit targeted, prospective studies to assess effectiveness of yellow fever vaccination programs, determine flavivirus seroprevalence across a broader age range, and investigate how these emerging diseases contribute to the burden of acute febrile illness in the DRC.

Indexed as

Seroepidemiologic StudiesAntibodies, ViralChild, PreschoolDemocratic Republic of the CongoDengueDengue VirusHumansInfantYellow FeverYellow Fever VaccineYellow fever virusZika VirusZika Virus InfectionAntibodies, ViralYellow Fever Vaccine

Identifiers

PMID29988000
PMCPMC6169194
OpenAlexW2860464972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.